Search research articles
Contact Us
Filters
Showing results (161-170 of 205) with videos related to
Page
of 21
Sort By:
European Radiology
|
February 28, 2016
Targeted MRI-guided prostate biopsy: are two biopsy cores per MRI-lesion required?
L Schimmöller, M Quentin, D Blondin, et al.
Magnetic Resonance Imaging
|
February 12, 2025
Use of deep learning-accelerated T2 TSE for prostate MRI: Comparison with and without hyoscine butylbromide admission
M Boschheidgen, L Drewes, B Valentin, et al.
European Journal of Radiology
|
December 24, 2021
Comparison of 3 T mpMRI and pelvic CT examinations for detection of lymph node metastases in patients with prostate cancer
B Valentin, C Arsov, T Ullrich, et al.
Der Urologe. Ausg. A
|
April 11, 2013
[PREFERE - the German prostatic cancer study: questions and claims surrounding study initiation in January 2013]
T Wiegel, P Albers, R Bussar-Maatz, et al.
Scientific Reports
|
April 26, 2022
Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate
M Boschheidgen, L Schimmöller, S Doerfler, et al.
Human Reproduction (Oxford, England)
|
February 10, 1998
Success of intracytoplasmic sperm injection in couples with male and/or female chromosome aberrations
M Montag, K van der Ven, S Ved, et al.
Der Urologe. Ausg. A
|
May 24, 2019
[Current research on pediatric and adult germ cell tumors : A report from the first "Düsseldorfer Testis Cancer Day"]
D Nettersheim, C Oing, S Schönberger, et al.
European Journal of Radiology
|
June 7, 2017
Magnetic resonance imaging of the prostate at 1.5 versus 3.0T: A prospective comparison study of image quality
T Ullrich, M Quentin, C Oelers, et al.
Data in Brief
|
November 25, 2022
Data on the detection of clinically significant prostate cancer by magnetic resonance imaging (MRI)-guided targeted and systematic biopsy
M Klingebiel, C Arsov, T Ullrich, et al.
European Journal of Radiology
|
February 16, 2021
Reasons for missing clinically significant prostate cancer by targeted magnetic resonance imaging/ultrasound fusion-guided biopsy
M Klingebiel, C Arsov, T Ullrich, et al.
Page
of 21
Search research articles
Search
Showing results (161-170 of 205) with videos related to
Sort By:
Page
of 21
European Radiology
|
February 28, 2016
Targeted MRI-guided prostate biopsy: are two biopsy cores per MRI-lesion required?
L Schimmöller, M Quentin, D Blondin, et al.
Magnetic Resonance Imaging
|
February 12, 2025
Use of deep learning-accelerated T2 TSE for prostate MRI: Comparison with and without hyoscine butylbromide admission
M Boschheidgen, L Drewes, B Valentin, et al.
European Journal of Radiology
|
December 24, 2021
Comparison of 3 T mpMRI and pelvic CT examinations for detection of lymph node metastases in patients with prostate cancer
B Valentin, C Arsov, T Ullrich, et al.
Der Urologe. Ausg. A
|
April 11, 2013
[PREFERE - the German prostatic cancer study: questions and claims surrounding study initiation in January 2013]
T Wiegel, P Albers, R Bussar-Maatz, et al.
Scientific Reports
|
April 26, 2022
Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate
M Boschheidgen, L Schimmöller, S Doerfler, et al.
Human Reproduction (Oxford, England)
|
February 10, 1998
Success of intracytoplasmic sperm injection in couples with male and/or female chromosome aberrations
M Montag, K van der Ven, S Ved, et al.
Der Urologe. Ausg. A
|
May 24, 2019
[Current research on pediatric and adult germ cell tumors : A report from the first "Düsseldorfer Testis Cancer Day"]
D Nettersheim, C Oing, S Schönberger, et al.
European Journal of Radiology
|
June 7, 2017
Magnetic resonance imaging of the prostate at 1.5 versus 3.0T: A prospective comparison study of image quality
T Ullrich, M Quentin, C Oelers, et al.
Data in Brief
|
November 25, 2022
Data on the detection of clinically significant prostate cancer by magnetic resonance imaging (MRI)-guided targeted and systematic biopsy
M Klingebiel, C Arsov, T Ullrich, et al.
European Journal of Radiology
|
February 16, 2021
Reasons for missing clinically significant prostate cancer by targeted magnetic resonance imaging/ultrasound fusion-guided biopsy
M Klingebiel, C Arsov, T Ullrich, et al.
Page
of 21